Furthermore, eNOS upregulation in LSP1 KO mice could be a compensatory mechanism against high blood pressure in LSP1 KO mice that appears to restore NO bioavailability and to ameliorate for increased cleavage/dissociation of eNOS in vivo in LSP1 KO mice. The gene discussed is LSP1; the disease is hypertensive disorder.